Company: CDT
Filing Date: 2025-12-12
Form Type: 8-K
Source: 0001493152-25-027489
Chunk: 0

Company: CDT Equity Inc.
Filing Date: 2025-12-12
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item      Entry                                  

On
December 8, 2025, CDT Equity Inc. (the “ Company”) and Corvus Capital Limited (“ Corvus”) entered into a Sale and
Purchase Agreement (the “ Agreement”) for the issuance of all of the outstanding shares of Conduit Pharmaceuticals Limited
(“ CPL”) held of record by the Company (the “ CPL Share”), 224,800 shares of common stock, par value $0.0001 per
share (the “ Common Stock”) of the Company (the “ CDT Shares”), and 3,685,815 pre-funded warrants (the “ Pre-Funded
Warrants”) to purchase shares of Common Stock (the “ Pre-Funded Warrant Shares”) collectively to Corvus. The issuance
to Corvus was in connection with the sale of CPL, a current subsidiary of the Company, that has been the subject of an ongoing
litigation as previously disclosed. The Company sold CPL, including the potential liability associated with the litigation, to
Corvus, a wholly-owned subsidiary of the Company’s Chief Executive Officer for a settlement amount of $7,000,000 that was satisfied
through the issuance of the CDT Shares and Pre-Funded Warrants. Prior to the execution of the Agreement, CPL transferred its shareholding
in its wholly-owned subsidiary, CDT Equity Ltd, to the Company in order to simplify the Company’s organizational structure.

The
ability to exercise any or all of the Pre-Funded Warrant Shares is subject to stockholder approval under applicable rules and regulations
of The Nasdaq Stock Market LLC, to the extent required by such rules and regulations (“ Stockholder Approval”). Under the
terms of the Pre-Funded Warrants, Corvus will not have the right to exercise any portion of the Pre-Funded Warrants if Corvus (together
with its affiliates) would beneficially own in excess of 49.99% of the number of the Company’s Common Stock outstanding immediately
after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Pre-Funded Warrants.

Pursuant
to the Agreement, the Company agreed to file a resale registration statement (the “ Resale Registration Statement”) to register
the resale of the CDT Shares and Pre-Funded Warrant Shares as soon as practicable, and to use commercially reasonable efforts to have
the Resale Registration Statement declared effective by the Commission and to keep such registration statement effective at